Article Details
Retrieved on: 2022-03-01 08:46:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's rare diseases unit Alexion and Neurimmune will work on evaluating NI006, a monoclonal antibody for the treatment of transthyretin ...
Article found on: wtvbam.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here